DPP4 Inhibitors and COVID-19–Holy Grail or Another Dead End?
Author:
Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Immunology,Immunology and Allergy
Link
https://link.springer.com/content/pdf/10.1007/s00005-020-00602-5.pdf
Reference63 articles.
1. Abbott CA, McCaughan GW, Levy MT et al (1999) Binding to human dipeptidyl peptidase IV by adenosine deaminase and antibodies that inhibit ligand binding involves overlapping, discontinuous sites on a predicted beta propeller domain. Eur J Biochem 266:798–810. https://doi.org/10.1046/j.1432-1327.1999.00902.x
2. Adil MS, Narayanan SP, Somanath PR (2020) Isamiloride a promising cardiovascular medication to persist in the COVID-19 crisis? Drug DiscovTher 14:256–258. https://doi.org/10.5582/ddt.2020.03070
3. Algaissi A, Agrawal AS, Han S et al (2019) Elevated human dipeptidyl peptidase 4 expression reduces the susceptibility of hDPP4 transgenic mice to Middle East Respiratory Syndrome coronavirus infection and disease. J Infect Dis 219:829–835. https://doi.org/10.1093/infdis/jiy574
4. Andrieu T, Thibault V, Malet I et al (2003) Similar increased serum dipeptidyl peptidase IV activity in chronic hepatitis C and other viral infections. J ClinVirol 27:59–68. https://doi.org/10.1016/s1386-6532(02)00128-2
5. Arulmozhiraja S, Matsuo N, Ishitsubo E et al (2016) Comparative binding analysis of dipeptidyl peptidase IV (DPP-4) with antidiabetic drugs - An ab initio fragment molecular orbital study. PLoS ONE 11:e0166275. https://doi.org/10.1371/journal.pone.0166275
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Systems medicine framework for repurposable drug combinations for COVID-19 comorbidities;Medicine in Omics;2024-08
2. Peptide Mold: A Novel Strategy for Mapping Potential Binding Sites in Protein Targets;2024-05-07
3. Peptide Mold: A Novel Strategy for Mapping Potential Binding Sites in Protein Targets;2024-02-29
4. Therapeutic effects of anti-diabetic drugs on traumatic brain injury;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2024-02
5. Diabetic individuals with COVID-19 exhibit reduced efficacy of gliptins in inhibiting dipeptidyl peptidase 4 (DPP4). A suggested explanation for increased COVID-19 susceptibility in patients with type 2 diabetes mellitus (T2DM);Life Sciences;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3